Last reviewed · How we verify
NCT04262700: CONVERT
Customer Outcomes & Value Experiencing A New Monitoring Technology
NA trial testing LifeScan's new BGMS in Diabetes Mellitus in 170 participants. Status unknown.
1 October 2020
Quick facts
| Lead sponsor | LifeScan Scotland Ltd |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 170 |
| Start date | 7 February 2020 |
| Primary completion | 1 October 2020 |
| Estimated completion | 1 October 2020 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- LifeScan's new BGMS
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
LifeScan Scotland Ltd
Who can join
16 and older, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate whether novel insight features in new Blood Glucose Monitoring System (BGMs) can improve glycemic control.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04262700
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other LifeScan Scotland Ltd trials
Trials by the same sponsor.
- NCT06052371 — Project VerioVue Enhancements - Neonate Study · terminated
- NCT06121856 — Project VerioVue Enhancements - Arterial Study · completed
- NCT03851549 — A User Performance and System Use Evaluation of a New Blood Glucose Monitoring System ( BGMS) · NA · unknown
- NCT03920085 — Clinical Evaluation of LifeScan Blood Glucose Monitoring Systems · NA · completed
- NCT03638349 — Actions & Insights Evaluating a Novel Diabetes Management Solution · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04262700 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by LifeScan Scotland Ltd
- Last refreshed: 9 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04262700.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing